AI
CLDX icon

Atom Investors’s Celldex Therapeutics CLDX Stock Holding History

Atom Investors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,179
Closed -$893K – 638
2025
Q1 		$893K Buy
49,179
+9,976
+25% +$223K 0.11% 220
2024
Q4 		$991K Buy
+39,203
New +$1.07M 0.12% 240
2024
Q3 		– Sell
-52,164
Closed -$1.93M – 485
2024
Q2 		$1.93M Buy
52,164
+7,024
+16% +$265K 0.19% 164
2024
Q1 		$1.89M Buy
45,140
+4,258
+10% +$175K 0.24% 143
2023
Q4 		$1.62M Buy
+40,882
New +$1.2M 0.29% 119
2023
Q2 		– Sell
-5,698
Closed -$205K – 305
2023
Q1 		$205K Buy
+5,698
New +$246K 0.11% 209
2022
Q1 		– Sell
-10,781
Closed -$417K – 224
2021
Q4 		$417K Buy
+10,781
New +$470K 0.07% 181

Other funds holding CLDX

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return